These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17318620)

  • 1. Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.
    Soysal A; Gokçe I; Pehlivan T; Bakir M
    Eur J Pediatr; 2007 Jun; 166(6):533-9. PubMed ID: 17318620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim.
    Ekwall E; Ulgemo A; Watson M; Boisnard F; Thomas S; Goullet F
    Vaccine; 2006 May; 24(20):4450-7. PubMed ID: 16621186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines.
    Bryan JP; Henry CH; Hoffman AG; South-Paul JE; Smith JA; Cruess D; Spieker JM; de Medina M
    Vaccine; 2000 Nov; 19(7-8):743-50. PubMed ID: 11115695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A.
    Zuckerman JN; Kirkpatrick CT; Huang M
    J Travel Med; 1998 Mar; 5(1):18-22. PubMed ID: 9772311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.
    Connor BA; Phair J; Sack D; McEniry D; Hornick R; Banerjee D; Jensen E; Kuter B
    Clin Infect Dis; 2001 Feb; 32(3):396-401. PubMed ID: 11170947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the immunogenicity and safety of 3 inactivated hepatitis A vaccines in Korean children aged 12 to 18 months: An open-label, randomized, prospective, multicenter study.
    Hong SS; Choi UY; Ma SH; Lee SY; Han SB; Kim KH; Kang JH; Kim JH
    Medicine (Baltimore); 2019 Feb; 98(6):e14364. PubMed ID: 30732169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of two doses of a paediatric hepatitis A vaccine in thai children: comparison of three vaccination schedules.
    Lolekha S; Pratuangtham S; Punpanich W; Bowonkiratikachorn P; Chimabutra K; Weber F
    J Trop Pediatr; 2003 Dec; 49(6):333-9. PubMed ID: 14725410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim.
    Clarke P; Kitchin N; Souverbie F
    Vaccine; 2001 Aug; 19(31):4429-33. PubMed ID: 11483268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.
    Van Der Wielen M; Vertruyen A; Froesner G; Ibáñez R; Hunt M; Herzog C; Van Damme P
    Pediatr Infect Dis J; 2007 Aug; 26(8):705-10. PubMed ID: 17848882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open study of inactivated hepatitis A vaccine (VAQTA) in Taiwanese healthy adult volunteers: safety, tolerability, and immunogenicity.
    Yang CY; Lu CY; Lee CY; Shao PL; Wang CY; Wu TZ; Huang LM
    J Microbiol Immunol Infect; 2004 Aug; 37(4):216-8. PubMed ID: 15340648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J
    Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
    Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
    Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.